Amyotrophic Lateral Sclerosis (ALS): Challenges and Progress
- 16 December 2023 17:30:45
- Views: 196
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects motor neurons, the nerve cells that control voluntary muscle movement. ALS is characterized by muscle weakness, spasticity, and progressive paralysis. The disease is always fatal, with most people living for 2 to 5 years after diagnosis.
Challenges
ALS is a complex disease with a long list of challenges. One of the biggest challenges is the lack of understanding of the disease's cause. While there is some evidence that ALS may be caused by a combination of genetic and environmental factors, the exact cause is still unknown.
Another challenge is the lack of effective treatments. There are currently no treatments that can cure ALS or stop the progression of the disease. The only available treatments are aimed at managing the symptoms and improving quality of life.
ALS is also a rare disease, with an estimated incidence of 2 to 3 cases per 100,000 people. This makes it difficult to conduct clinical trials and develop new treatments.
Progress
Despite the challenges, there has been significant progress in understanding and treating ALS in recent years.
One of the most important advances has been the discovery of genetic mutations that are associated with ALS. These mutations have led to the development of new animal models of ALS, which are essential for studying the disease and developing new treatments.
Another important advance has been the development of new drugs that target the underlying mechanisms of ALS. These drugs have shown some promise in slowing the progression of the disease, but more research is needed to determine their long-term effectiveness.
In addition to research on new treatments, there has also been progress in developing new ways to support people living with ALS. These include new assistive technologies, such as wheelchairs and speech-generating devices, as well as new services to help people with ALS and their families cope with the challenges of the disease.
Conclusion
ALS is a devastating disease, but there is hope for the future. With continued research and development, new treatments are likely to be developed that will improve the lives of people living with ALS.
Specific challenges and progress
Cause of ALS
The cause of ALS is still unknown, but there is evidence that it is a complex disease with a combination of genetic and environmental factors.
Genetic factors
About 10% of ALS cases are caused by inherited genetic mutations. These mutations can be passed down from parents to children, or they can occur spontaneously.
The most common inherited mutation associated with ALS is a mutation in the gene for superoxide dismutase 1 (SOD1). SOD1 is an enzyme that helps protect cells from damage caused by free radicals. Mutations in SOD1 can lead to the accumulation of free radicals, which can damage motor neurons.
Other genetic mutations that have been associated with ALS include mutations in the genes for TAR DNA-binding protein 43 (TDP-43), copper/zinc superoxide dismutase (Cu/Zn SOD), and fused in sarcoma (FUS).
Environmental factors
Environmental factors that may contribute to the development of ALS include exposure to toxins, such as lead, pesticides, and herbicides. Other possible environmental factors include exposure to viruses, such as the Epstein-Barr virus, and exposure to radiation.
Treatment for ALS
There is currently no cure for ALS, but there are a number of treatments available that can help to manage the symptoms and improve quality of life.
Riluzole
Riluzole is the only FDA-approved drug for the treatment of ALS. It is a glutamate antagonist that helps to reduce the damage caused by glutamate, a neurotransmitter that can be toxic to motor neurons.
Edaravone
Edaravone is a free radical scavenger that has been shown to slow the progression of ALS in some people.
Stem cell therapy
Stem cell therapy is a promising new treatment for ALS that is still in the early stages of development. Stem cells have the potential to replace damaged or dying motor neurons.
Support for people living with ALS
In addition to treatment, there are a number of services available to support people living with ALS. These services can help people to cope with the challenges of the disease, such as difficulty with mobility, communication, and swallowing.
Assistive technologies
Assistive technologies can help people with ALS to maintain their independence and quality of life. These technologies include wheelchairs, speech-generating devices, and computer-assisted communication systems.
Services for families
Families of people with ALS also need support. There are a number of organizations that provide support and resources for families of people with ALS
Buyers Online
- Customer from AL Jaddaf waterfront registered for an account
- Customer from BEN LOMOND logged in
- Customer from BEN LOMOND placed a new order for GROPRINOSIN FORTE 1000MG 30 TABS - MADE IN POLAND- FREE SHIPPING
- Customer from BEN LOMOND registered for an account
- Customer from POUGHKEEPSIE placed a new order for Nazoferon nasal drops 100,000 IU/ml 5 ml — Made in Ukraine — Free Delivery
- Customer from POUGHKEEPSIE updated their account details
- Customer from POUGHKEEPSIE registered for an account
- Customer from Loures registered for an account
- Customer from Holt logged in
- Customer placed a new order for Cerebrolysin solution for injection 215.2 mg/ml, 20 ml (4304 mg) x 5 ampoules — Made in Austria — Free Delivery
- Customer from Englewood logged in
- Customer from Englewood placed a new order for Regulon 0.15mg/0.03mg 63 tablets — Made in Hungary — Free Delivery
- Customer from Englewood logged in
- Customer from Bottenwil placed a new order for BRAVERA CONTROL 96MG/G AEROSOL 8ML — MADE IN POLAND — FREE SHIPPING
- Customer from Bottenwil registered for an account
- Customer from MONTGERON logged in
- Customer placed a new order for Actovegin solution for injection 200mg 2p x 5 ampoules (5ml) — Made in Ukraine — Free Delivery
- Customer from MONTGERON placed a new order for MILDRONATE 250MG 40 CAPS - MADE IN LATVIA - FREE SHIPPING
- Customer from MONTGERON logged in
- Customer from MONTGERON registered for an account
Latest
Bestsellers
















